Clinical trial
BIOTRONIK-Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in the Treatment of Patients With Single de Novo Coronary Artery Lesions in an Indian Population
NCT01426139 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIOTRONIK-Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in the Treatment of Patients With Single de Novo Coronary Artery Lesions in an Indian Population
- Lead sponsor
- Biotronik AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- February 28, 2013
- Enrollment
- 120 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.